Journal
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 40, Issue 6, Pages 639-646Publisher
NATURE PUBLISHING GROUP
DOI: 10.3858/emm.2008.40.6.639
Keywords
DLC1 protein, human; histone deacetylases; p300-CBP transcription factors; promoter regions, genetic; Sp1 transcription factor; trichostation A
Funding
- Ministry of Science and Technology of Korea through the National Research Laboratory Program for Cancer Epigenetics
- BK21 Project for Medicine, Dentistry, and Pharmacy
Ask authors/readers for more resources
We previously reported that trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, induced DLC-1 mRNA expression and accumulated acetylated histones H3 and H4 associated with the DLC-1 promoter in DLC-1 non-expressing gastric cancer cells. In this study, we demonstrated the molecular mechanisms by which TSA induced the DLC-1 gene expression. Treatment of the gastric cancer cells with TSA activates the DLC-1 promoter activity through Sp1 sites located at -219 and -174 relative to the transcription start site. Electrophoretic mobility-shift assay (EMSA) revealed that Sp1 and Sp3 specifically interact with these Sp1 sites and showed that TSA did not change their binding activities. The ectopic expression of Sp1, but not Sp3, enhances the DLC-1 promoter responsiveness by TSA. Furthermore, the TSA-induced DLC-1 promoter activity was increased by p300 expression and reduced by knockdown of p300. These results demonstrated the requirement of specific Sp1 sites and dependence of Sp1 and p300 for TSA-mediated activation of DLC-1 promoter.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available